As we all anxiously wait for the FDA to finally make a determination about the pending application for approval of the investigational androgen biosynthesis inhibitor abiraterone acetate more data rolls in showing that supports the need to have a speedy approval. A new study published March 1, 2011, out of Italy adds support to the [...]
Malecare Celebrates 10 years of online prostate cancer support for gay men. Russ Windle on today's 10 year celebration: Congratulations to all the men past and present who have made this group a viable resource for gay men dealing with the effects of prostate cancer in their lives. You have made this group what it [...]
Posted: March 18, 2011 10:24 AM : The Huffington Post "At last week's Innovative Minds in Prostate Cancer meeting, the speakers included not only doctors, but patients. We patients also help review the grant applications of the scientists. We seek innovative proposals to cure or slow prostate cancer, or reduce its notorious pain, and the [...]
If you read my previous post ,you will see Senator McCain’s plan to eliminate the Prostate Cancer Research Program within the Congressionally Directed Medical Research Program (CDMRP). The loss of this program could shorten many of our lives and add significantly to our pain and suffering. Now is the time to work with the rest of [...]
A new Phase 2 clinical trial of tesetaxel in men with castrate resistant advanced prostate cancer will be conducted through the Prostate Cancer Clinical Trials Consortium (PCCTC). Tesetaxel, an oral taxane which is in clinical development, will be evaluated for its use as both first- and second-line chemotherapy. […]